Information Provided By:
Fly News Breaks for May 10, 2019
May 10, 2019 | 05:00 EDT
Cantor Fitzgerald analyst Alethia Young downgraded Puma Biotechnology to Neutral from Overweight and lowered her price target for the shares to $20 from $57. The visibility of the Nerlynx is low in 2019, Young tells investors in a research note following Puma's Q1 results.
News For PBYI From the Last 2 Days
There are no results for your query PBYI